Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Olivotto I,Oreziak A,Barriales-Villa R,Abraham T,Masri A,Garcia-Pavia P,Saberi S,Lakdawala N,Wheeler M,Owens A,Kubanek M,Wojakowski W,Jensen M,Gimeno-Blanes J,Afshar K,Myers J,Hegde S,Solomon S,Sehnert A,Zhang D,Li W,Bhattacharya M,Edelberg J,Waldman C,Lester S,Wang A,Ho C,Jacoby D,Bartunek J,Bondue A,Van Craenenbroeck E,Zemanek D,Jensen M,Mogensen J,Thune J,Charron P,Hagege A,Lairez O,Trochu J,Axthelm C,Duengen H,Frey N,Mitrovic V,Preusch M,Schulz-Menger J,Seidler T,Arad M,Halabi M,Katz A,Monakier D,Paz O,Viskin S,Zwas D,Brunner-La Rocca H,Michels M,Dudek D,Oko-Sarnowska Z,Cardim N,Pereira H,García Pavia P,Gimeno Blanes J,Hidalgo Urbano R,Rincón Diaz L,Elliott P,Yousef Z,Abraham T,Alvarez P,Bach R,Becker R,Choudhury L,Fermin D,Jefferies J,Kramer C,Lakdawala N,Lester S,Marian A,Maurer M,Nagueh S,Owens D,Rader F,Sherrid M,Shirani J,Symanski J,Turer A,Wever-Pinzon O,Wheeler M,Wong T,Yamani M
Source :
Pmid / DOI: